Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Architecture of the complete oxygen-sensing FixL-FixJ two-component signal transduction system.

Wright GSA, Saeki A, Hikima T, Nishizono Y, Hisano T, Kamaya M, Nukina K, Nishitani H, Nakamura H, Yamamoto M, Antonyuk SV, Hasnain SS, Shiro Y, Sawai H.

Sci Signal. 2018 Apr 10;11(525). pii: eaaq0825. doi: 10.1126/scisignal.aaq0825.

PMID:
29636388
2.

Expression of Maternal Embryonic Leucine Zipper Kinase (MELK) Correlates to Malignant Potentials in Hepatocellular Carcinoma.

Hiwatashi K, Ueno S, Sakoda M, Iino S, Minami K, Yonemori K, Nishizono Y, Kurahara H, Mataki Y, Maemura K, Shinchi H, Natsugoe S.

Anticancer Res. 2016 Oct;36(10):5183-5188.

PMID:
27798878
3.

Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen.

Kurahara H, Bohl C, Natsugoe S, Nishizono Y, Harihar S, Sharma R, Iwakuma T, Welch DR.

Int J Cancer. 2016 Aug 1;139(3):628-38. doi: 10.1002/ijc.30110.

4.

The clinical usefulness of the intraoperative detection of sentinel lymph node metastases by a rapid RT-PCR system in patients with gastric cancer.

Yanagita S, Uenosono Y, Arigami T, Daisuke M, Okubo K, Kijima T, Arima H, Hirata M, Haraguchi N, Hagihara T, Nishizono Y, Ishigami S, Natsugoe S.

Cancer. 2016 Feb 1;122(3):386-92. doi: 10.1002/cncr.29740. Epub 2015 Oct 19.

5.

Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma.

Matsushita D, Uenosono Y, Arigami T, Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima H, Kijima Y, Kurahara H, Maemura K, Okumura H, Ishigami S, Natsugoe S.

Ann Surg Oncol. 2015 Oct;22(11):3674-80. doi: 10.1245/s10434-015-4392-8. Epub 2015 Feb 5.

6.

Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer.

Kawasaki Y, Ishigami S, Arigami T, Uenosono Y, Yanagita S, Uchikado Y, Kita Y, Nishizono Y, Okumura H, Nakajo A, Kijima Y, Maemura K, Natsugoe S.

BMC Cancer. 2015 Jan 15;15:5. doi: 10.1186/s12885-015-1008-4.

7.

Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.

Kita Y, Nishizono Y, Okumura H, Uchikado Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, Owaki T, Ishigami S, Nakagawa H, Tanaka F, Mimori K, Mori M, Natsugoe S.

Oncol Rep. 2014 May;31(5):1986-92. doi: 10.3892/or.2014.3062. Epub 2014 Mar 5.

PMID:
24604089
8.

Clinical implications of DLL4 expression in gastric cancer.

Ishigami S, Arigami T, Uenosono Y, Okumura H, Kurahara H, Uchikado Y, Setoyama T, Kita Y, Kijima Y, Nishizono Y, Nakajo A, Owaki T, Ueno S, Natsugoe S.

J Exp Clin Cancer Res. 2013 Jul 30;32:46. doi: 10.1186/1756-9966-32-46.

9.

Clinical-pathological implication of human leukocyte antigen-F-positive gastric adenocarcinoma.

Ishigami S, Arigami T, Setoyama T, Okumura H, Sasaki K, Uchikado Y, Kurahara H, Kijima Y, Nishizono Y, Nakajo A, Natsugoe S.

J Surg Res. 2013 Oct;184(2):802-6. doi: 10.1016/j.jss.2013.04.003. Epub 2013 Apr 26.

PMID:
23706560
10.

Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.

Ishigami S, Arigami T, Uenosono Y, Matsumoto M, Okumura H, Uchikado Y, Kita Y, Nishizono Y, Maemura K, Kijima Y, Nakajo A, Owaki T, Ueno S, Hokita S, Natsugoe S.

Cancer Immunol Immunother. 2012 Oct;61(10):1663-9. Epub 2012 Feb 29.

PMID:
22374482
11.

Prognostic impact of CD168 expression in gastric cancer.

Ishigami S, Ueno S, Nishizono Y, Matsumoto M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki K, Kijima Y, Kitazono M, Natsugoe S.

BMC Cancer. 2011 Mar 24;11:106. doi: 10.1186/1471-2407-11-106.

12.

Clinical implication of CD166 expression in gastric cancer.

Ishigami S, Ueno S, Arigami T, Arima H, Uchikado Y, Kita Y, Sasaki K, Nishizono Y, Omoto I, Kurahara H, Matsumoto M, Kijima Y, Natsugoe S.

J Surg Oncol. 2011 Jan 1;103(1):57-61. doi: 10.1002/jso.21756.

PMID:
20886585
13.
16.

Hypercholinesterasemia in patients with hepatocellular carcinoma: a new paraneoplastic syndrome.

Tajiri J, Nishizono Y, Fujiyama S, Sagara K, Sato T, Shibata H.

Gastroenterol Jpn. 1983 Apr;18(2):137-41.

PMID:
6303885
17.

[Inhibition of insulin action by bovine plasma albumin (author's transl)].

Ueki H, Nishizono Y, Funakoshi T, Shoji S, Kubota Y.

Yakugaku Zasshi. 1977 Jul;97(7):816-20. Japanese. No abstract available.

PMID:
911417

Supplemental Content

Loading ...
Support Center